How we treat endocrine complications of immune checkpoint inhibitors
2021 · ESMO Open · 65 citations
https://doi.org/10.1016/j.esmoop.2020.100011
K
Konstantinos Koutsoukos
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
932
Citations
18
h-index
28
i10-index
Konstantinos Koutsoukos is an academic researcher from Metropolitan Hospital. The author has contributed to research in topics: Renal cell carcinoma treatment & Ovarian cancer diagnosis and treatment & Cancer Genomics and Diagnostics. The author has an h-index of 18, co-authored 81 publications.
ORCID: 0000-0002-1710-125XPapers by this author
worksSynchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consortium
2020 · European Urology Oncology · 57 citations
https://doi.org/10.1016/j.euo.2020.01.001
The emerging role of BET inhibitors in breast cancer
2020 · The Breast · 45 citations
https://doi.org/10.1016/j.breast.2020.08.005
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors
2021 · The Breast · 21 citations
https://doi.org/10.1016/j.breast.2021.08.017
Axitinib as a third or further line of treatment in renal cancer: a single institution experience
2020 · BMC Urology · 3 citations
https://doi.org/10.1186/s12894-020-00618-1
Predictive tissue markers in testicular germ cell tumors: Immunohistochemical expression of MLH1 and REV-7 proteins
2024 · International Urology and Nephrology · 2 citations
https://doi.org/10.1007/s11255-023-03933-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat